Sección Fisiología & Genética Bacterianas, Facultad de Ciencias, Iguá 4225, Montevideo, 11.400, Uruguay.
Microb Pathog. 2021 Dec;161(Pt A):105206. doi: 10.1016/j.micpath.2021.105206. Epub 2021 Oct 4.
Antibiotic resistance is a health concern. Class 1 integrons (Int1) are genetic elements that contribute to the problem, as they carry different antibiotic resistance genes in their variable region, frequently dfrA (resistance to trimethoprim) and, in their conserved region, the sul1 gene (resistance to sulfonamides, e.g. sulfamethoxazole). These are synthetic antibiotics that work by blocking two enzymes in the folic acid synthesis pathway. In the clinic, the combination of trimethoprim (TMP) and sulfamethoxazole (SMX), called co-trimoxazole (SXT), is widely used. A collection of 230 uropathogenic Escherichia coli strains was studied with three objectives: i) to analyze their phenotype of susceptibility to antifolate antibiotics, ii) to determine the genetic basis of their resistance to SMX, and iii) to correlate the phenotypic and genotypic data with the presence of Int1. The prevalence of resistance to SMX, TMP, and SXT was 54%, 45%, and 41%, respectively. The mobile genes sul1, sul2 and sul3, which confer resistance to sulfonamides, were PCR-surveyed: all sulfa-resistant strains were found to contain at least one of these genes, with the exception of three strains. For these latter, the possibility of being target folP mutants could be ruled out, pointing to the existence of a still unknown mechanism of resistance to SMX in E. coli. All 50 strains previously cataloged as positive for Int1 (because they had an intI1 gene for the integrase) were resistant to SMX: most had sul1, alone or with sul2 or sul3, others only had sul2, and one lacked every sul gene. In addition, 16 sul1intI1 strains were found to contain other typical integron sequences. That is, in no case was the sul1 gene detected independently of other Int1 sequences. Therefore, we propose that the sul1 gene would be a good marker for the presence of Int1, as well as the intI1 gene. Following this criterion, the prevalence of Int1 in our collection increased from 22% (50 intI1) to 29% (66 intI1 and/or sul1). Of these 66 Int1 strains, 63 were resistant to TMP. The main conclusion in this work is that the presence of a class 1 integron would always require a sulfamethoxazole resistant cellular context. In more general terms, these integrons appear to be closely related to resistance to antifolate compounds.
抗生素耐药性是一个健康问题。1 类整合子(Int1)是导致该问题的遗传因素,因为它们在可变区携带不同的抗生素耐药基因,通常是 dfrA(对甲氧苄啶的耐药性),在其保守区携带 sul1 基因(对磺胺类药物的耐药性,例如磺胺甲恶唑)。这些是通过阻断叶酸合成途径中的两种酶起作用的合成抗生素。在临床上,甲氧苄啶(TMP)和磺胺甲恶唑(SMX)的组合,称为复方新诺明(SXT),被广泛使用。本研究对 230 株尿路致病性大肠埃希菌进行了研究,目的有三:i)分析其对叶酸类抗生素的药敏表型,ii)确定其对 SMX 耐药的遗传基础,iii)将表型和基因型数据与 Int1 的存在相关联。对 SMX、TMP 和 SXT 的耐药率分别为 54%、45%和 41%。对磺胺类药物耐药的移动基因 sul1、sul2 和 sul3 进行了 PCR 检测:除了 3 株菌之外,所有磺胺类耐药株均携带这些基因中的至少一个基因,对于这 3 株菌,可排除其为靶位 folP 突变体的可能性,表明大肠埃希菌对 SMX 的耐药机制尚不清楚。之前因含有整合酶基因 intI1 而被归类为 Int1 阳性的 50 株菌均对 SMX 耐药:大多数菌同时携带 sul1 基因,或携带 sul2 或 sul3 基因,其他菌仅携带 sul2 基因,而 1 株菌则缺失所有 sul 基因。此外,还发现 16 株 sul1intI1 菌株含有其他典型的整合子序列。也就是说,sul1 基因从未被检测到独立于其他 Int1 序列之外。因此,我们提出 sul1 基因可以作为 Int1 存在的良好标志物,同时也是 intI1 基因。按照这一标准,我们的研究中 Int1 的流行率从 22%(50 株 intI1)增加到 29%(66 株 intI1 和/或 sul1)。在这 66 株 Int1 菌株中,有 63 株对 TMP 耐药。本工作的主要结论是,1 类整合子的存在总是需要磺胺甲恶唑耐药的细胞环境。更一般地说,这些整合子似乎与抗叶酸化合物的耐药性密切相关。